Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Adverse Reactions Up 134 Percent In Hubei

This article was originally published in PharmAsia News

Executive Summary

Hubei Provincial FDA announced there were 11,089 reports of adverse reactions to drugs in 2008, up 134.99 percent from 2007. The significant increase represents heightened awareness of adverse reactions. Statistics show that 55.99 percent of the reports are related to antibiotics, which highlights the abuse and misuse of antibiotics in China. According to the "Drug Administration Law" and "Statute Governing the Report and Administration of Adverse Reaction to Drugs," pharmaceutical manufacturers, companies and medical institutions are all responsible for reporting adverse events, yet only 0.2 percent of the reports were filed by drug makers. The authorities plan on targeting them for future improvement. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC070903

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel